TP53 and neoplasm: This evidence suggests that HG-SOC tumor progression within the fallopian tube fimbria begins with TP53 mutations (p53 signatures), evolves to serous tubal intraepithelial carcinoma (STIC), and eventually transforms and metastasizes to the ovary presenting as HG-SOC (20, 24) (Figure 2).